XBIO

Valor Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM Total revenue 648.82 K593.26 K589.9 K1.03 M766.3 K 2.98 M Gross profit 648.82 K593.26 K589.9 K1.03 M766.3 K 2.98 M Operating expenses 1.75 M1.54 M1.31 M1.57 M1.39 M 5.81 M Selling/general/admin expenses 705.71 K656.64 K657.75 K815.21 K615.91 K 2.75 M Research & development 1.04 M879.03 K656.56 K756.48 K773.42 K 3.07 M Operating income -1.1 M-942.41 K-724.41 K-544.73 K-623.03 K -2.83 M Non-Operating Income, Total 44.62 K39.27 K35.71 K34.79 K43.95 K 153.72 K Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses 51.87 K39.19 K34.23 K30.78 K43.79 K 148 K Unusual income/expense -7 243781 4774 011159 5 725 Pretax income -1.05 M-903.14 K-688.7 K-509.94 K-579.08 K -2.68 M Equity in earnings ————— — Taxes 00000 0 Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations -1.05 M-903.14 K-688.7 K-509.94 K-579.08 K -2.68 M Discontinued operations ————— — Net income -1.05 M-903.14 K-688.7 K-509.94 K-579.08 K -2.68 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -1.05 M-903.14 K-688.7 K-509.94 K-579.08 K -2.68 M Basic earnings per share (Basic EPS) -0.68-0.59-0.45-0.33-0.21 -1.58 Diluted earnings per share (Diluted EPS) -0.68-0.59-0.45-0.33-0.21 -1.58 Average basic shares outstanding 1.54 M1.54 M1.54 M1.54 M1.7 M 6.33 M Diluted shares outstanding 1.54 M1.54 M1.54 M1.54 M1.7 M 6.33 M EBITDA ————— — EBIT -1.1 M-942.41 K-724.41 K-544.73 K-623.03 K -2.83 M Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) ————— —